|
|
|
| Clinical effect of inhaled hormone combined with Tiotropium Bromide in the treatment of asthma chronic obstructive pulmonary overlap syndrome |
| ZHENG Yan-bing |
| People′s Hospital of Dongguan City,Guangdong Province,Dongguan 523000,China |
|
|
|
|
Abstract ObjectiveTo study the clinical effect of asthma and COPD overlap syndrome （ACOS） of inhaled corticosteroid combined with Tiotropium therapy.MethodsFrom January 2016 to June 2017,100 patients who met the criteria for diagnosis of ACOS were selected.They were divided into two groups according to the different treatment drugs：Sulidide combined with Tiotropium Bromide inhalation group (experimental group,60 cases)and Sulidide inhalation group(control group,40 cases).The pulmonary function indexes were compared before and after treatment.The scores of asthma symptom,chronic obstructive pulmonary symptom and acute exacerbation were compared between the two groups before and after treatment,and the occurrence of adverse reactions in the two groups was compared.ResultsThere was no significant difference in lung function between the two groups before treatment(P＞0.05).After treatment,the lung function of the two groups was improved,but the lung function index of the experimental group was better than that of the control group after treatment,the differences were statistically significant(P<0.05).ACT,CAT,COPD score and acute exacerbation times showed no significant difference between the two groups before treatment(P＞0.05).ACT,CAT of two groups after treatment were significantly decreased,the frequency of acute exacerbation was significantly reduced,but the experimental group after treatment score and acute exacerbation times were better than the control group,the differences were statistically significant(P<0.05).The incidence of adverse drug reactions in the experimented group was lower than that of the control group,the difference was statistically significant (P<0.05).ConclusionThe effects of Sulidide inhalation combined with Tiotropium Bromide in ACOS are good,and the prognosis of patients can be improved.
|
|
|
|
|
|
| [1] |
刘媛媛，克丽别娜·吐尔逊，迪丽努尔，等.类固醇激素联合β2受体激动剂对哮喘-慢性阻塞性肺疾病重叠综合征的短期疗效[J].实用医学杂志，2017，33（15）：2439-2442.
|
| [2] |
叶永军.支气管哮喘-慢性阻塞性肺疾病急性加重期重叠综合征 1 例报告[J].中国实用内科杂志，2016，36（S2）：152-154.
|
| [3] |
吉泽，潘星，姬峰，等.呼出气一氧化氮检测在哮喘-慢阻肺重叠综合征治疗中的应用价值[J].第二军医大学学报，2016，37（10）：1250-1255.
|
| [4] |
崔家玉，谢晓慧.新指南中支气管哮喘和慢性阻塞性肺疾病的药物治疗比较[J].中国医院药学杂志，2016，36（21）：1897-1900.
|
| [5] |
徐飞，董竞成.哮喘-慢性阻塞性肺疾病重叠综合征的临床研究进展[J].中国全科医学，2016，19（5）：500-506.
|
| [6] |
万敏，唐小婷，张巧，等.哮喘-慢阻肺重叠综合征患者240例临床特征分析[J].第三军医大学学报，2015，37（21）：2181-2185.
|
| [7] |
陈晓青.噻托溴铵联合大剂量沙美特罗替卡松粉吸入剂治疗重度支气管哮喘合并慢性阻塞性疾病的疗效观察[J].中国医院药学杂志，2013，33（13）：1075-1078.
|
| [8] |
孟珊珊，闫冰迪，王艳军，等.支气管哮喘-慢性阻塞性肺疾病重叠综合征 265 例[J].实用医学杂志，2015，31（3）：437-438.
|
| [9] |
Fu JJ，Gibson PG，Simpson JL，et al.Longitudinal changes in clinical outcomes in older patients with asthma，COPD and asthma-COPD overlap syndrome[J].Respiration，2014，87（1）：63-74.
|
| [10] |
Nakawah MO，Hawkins C，Barbandi F，et al.Asthma， chronic obstructive pulmonary disease （COPD），and the overlap syndrome[J].J Am Board Fam Med，2013，26（4）：470-477.
|
| [11] |
Kauppi P，Kupiainen H，Lindqvist A，et al.Overlap syndrome of asthma and COPD predicts low quality of life[J].J Asthma，2011，48（3）：279-285.
|
| [12] |
Gibson PG，Simpson JL.The overlap syndrome of asthma and COPD：what are its features and how important is it？[J].Thorax，2009，64（8）：728-735.
|
| [13] |
BarrechegurenM，EsquinasC，MiravitllesM，etal.Theasthmachronic obstructive pulmonary disease overlap syndrome（ACOS）：opportunities and challenges[J].Curr Opin Pulm Med，2015，21（1）：74-79.
|
| [14] |
麻佑锋，郑有光，韩利红.哮喘-慢阻肺重叠综合症患者诱导痰细胞计数及血清降钙素原检测的意义[J].临床肺科杂志，2017，22（9）：1628-1630.
|
| [15] |
陈石，李磊，吴刚，等.吸入激素联合噻托溴铵治疗哮喘-慢阻肺重叠综合症的临床疗效评价[J].临床肺科杂志，2015，20（10）：1856-1860.
|
|
|
|
